Хайлтын үр дүнгүүд - Adam Walter
- 8-н 1 - 8 үр дүнгүүдийг харуулж байна
-
1
-
2
Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product -н David Willoughby, Ernest Bognar, Laura Stanbery, Casey Nagel, Gladice Wallraven, Aman Pruthi, Nicholas Bild, Ericca Stamper, Donald Rao, Adam Walter, John Nemunaitis
Хэвлэсэн 2025Artigo -
3
Current Ovarian Cancer Maintenance Strategies and Promising New Developments -н Vinaya Gogineni, Susan Morand, Hannah Staats, Rachel Royfman, Monika Devanaboyina, Katelyn R. Einloth, Danielle Dever, Laura Stanbery, Phylicia Aaron, Luisa Manning, Adam Walter, Gerald M. Edelman, Lance D. Dworkin, John Nemunaitis
Хэвлэсэн 2020Revisão -
4
A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases -н Neil Miller, Emily Farrow, Margaret Gibson, Laurel K. Willig, Greyson P Twist, Byunggil Yoo, T. C. Marrs, Shane Corder, Lisa Ann Krivohlavek, Adam Walter, Josh E Petrikin, Carol Saunders, Isabelle Thiffault, Sarah Soden, Laurie D. Smith, Darrell L. Dinwiddie, Suzanne Herd, Julie A. Cakici, Severine Catreux, Mike Ruehle, Stephen F. Kingsmore
Хэвлэсэн 2015Artigo -
5
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: <scp>ELOQUENT</scp>‐2 follow‐up and <i>post‐hoc</i> analyses on progression‐free survival an... -н Meletios Α. Dimopoulos, Sagar Lonial, Darrell White, Philippe Moreau, Antonio Palumbo, Jesús F. San Miguel, Ofer Shpilberg, Kenneth C. Anderson, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Hila Magen, María‐Victoria Mateos, Andrew R. Belch, Donna Reece, Meral Beksaç, Eric Bleickardt, Valerie Poulart, Jennifer Sheng, Oumar Sy, Jessica Katz, Anil Singhal, Paul G. Richardson
Хэвлэсэн 2017Artigo -
6
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma -н Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo, Darrell White, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Philippe Moreau, María‐Victoria Mateos, Hila Magen, Andrew R. Belch, Donna Reece, Meral Beksaç, Andrew Spencer, Heather Oakervee, Robert Z. Orlowski, Masafumi Taniwaki, Christoph Röllig, Hermann Einsele, Ka Lung Wu, Anil Singhal, Jesús F. San Miguel, Morio Matsumoto, Jessica Katz, Eric Bleickardt, Valerie Poulart, Kenneth C. Anderson, Paul G. Richardson
Хэвлэсэн 2015Artigo -
7
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study -н Meletios Α. Dimopoulos, Sagar Lonial, Darrell White, Philippe Moreau, Katja Weisel, Jesús F. San Miguel, Ofer Shpilberg, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Hila Magen, María‐Victoria Mateos, Andrew R. Belch, Donna Reece, Meral Beksaç, Andrew Spencer, Heather Oakervee, Robert Z. Orlowski, Masafumi Taniwaki, Christoph Röllig, Hermann Einsele, Morio Matsumoto, Ka Lung Wu, Kenneth C. Anderson, Ying‐Ming Jou, Alex Ganetsky, Anil Singhal, Paul G. Richardson
Хэвлэсэн 2020Artigo -
8
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): inte... -н Dominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak, Tadeusz Kubicki, Paweł Robak, Adam Walter‐Croneck, Jarosław Czyż, Agata Tyczyńska, Agnieszka Druzd‐Sitek, Krzysztof Giannopoulos, Adam Nowicki, Tomasz Szczepaniak, Anna Łojko‐Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Puła, Justyna Rybka, Maciej Majcherek, Lidia Usnarska‐Zubkiewicz, Łukasz Szukalski, Agnieszka Końska, Jan Maciej Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Oscar Lahoud, Jeffrey A. Zonder, Kent A. Griffith, Andrew Stefka, Ajay Major, Benjamin A. Derman, Andrzej Jakubowiak
Хэвлэсэн 2023Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Internal medicine
Medicine
Oncology
Biology
Chemotherapy
Dexamethasone
Lenalidomide
Multiple myeloma
Confidence interval
Genetics
Hazard ratio
Adverse effect
Bioinformatics
Cancer
DNA
DNA sequencing
Disease
Gene
Intensive care medicine
Interim analysis
Progression-free survival
Randomized controlled trial
Surgery
Archaeology
Astrobiology
Autologous stem-cell transplantation
BRCA mutation
Bevacizumab
Bortezomib
Cancer research